Janice M. Smiell

Original Research

Real-world Experience With a Decellularized Dehydrated Human Amniotic Membrane Allograft

06/15/2015

Janice M. Smiell ;

Helen D. Hahn ;

Terry Treadwell , MD, FACS, FAAWC;

Michel H.E. Hermans , MD;

06/15/2015

Wounds

The Rebirth of Regenerative Medicine in Wound Care

04/16/2015

Janice M. Smiell ;

Use of amniotic membrane allografts to treat chronic wounds is on the incline due to a better understanding of its positive effects.

Use of amniotic membrane allografts to treat chronic wounds is on the incline due to a better understanding of its positive effects.

Use of amniotic membrane...

04/16/2015

Today's Wound Clinic

Original Research

Modulation of Cell Attachment, Proliferation, and Angiogenesis by Decellularized, Dehydrated Human Amniotic Membrane in In Vitro Models

10/27/2016

Aleksandr Kaplunovsky ;

Vladimir Jankovic ;

Ivana Djuretic ;

Chuan Wang , MD;

Joseph Gleason ;

Janice M. Smiell ;

Jeffrey Turner ;

Wolfgang Hofgartner ;

Robert Hariri ;

10/27/2016

Wounds

Healthcare Resource Utilization and Costs of Care Among Pediatric Patients with Thermal Burns Undergoing Inpatient Autografting in a US Managed Care Population

Autograft is considered the standard of care for severe burns; however, data on the economic outcomes in the pediatric population are sparse. This study assessed the healthcare resource u...

Tzy-Chyi Yu , MHA;

Hiangkiat Tan ;

Helen D. Hahn ;

Janice M. Smiell ;

Chia-Chen Teng ;

11/23/2020

Exploring Cost and Treatment Patterns During Hospitalizations for Thermal Burn Patients Undergoing Autografting in a Commercially Insured Population

Autografting is included in current standard of care for severe burns; however, little is known about economic outcomes among thermal burn patients who undergo inpatient autografting. Thi...

Janice M. Smiell ;

Tzy-Chyi Yu , MHA;

12/11/2019

The Regulatory Environment for Tissue-Engineered Products for the Treatment of Burns in the United States

Background: Tissue engineering (TE) is defined by the National Institutes of Health as the practice of combining scaffolds, cells, and biologically active molecules into functional t...

Janice M. Smiell ;

Kimberly Belsky ;

Mary A. Lokuta ;

07/29/2019

Featured CME Course

Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes

Upcoming Events

February 2 ⁠–⁠ February 5

February 7 ⁠–⁠ February 9

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

March 22 ⁠–⁠ March 23

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

WoundCon

May 1 ⁠–⁠ May 3

See Full Calendar